CONTEXT: Roux-en-Y gastric bypass (RYGB) is among the most effective treatments for extreme obesity and obesity-related complications. However, despite its potential efficacy, many patients do not achieve and/or maintain sufficient weight loss. OBJECTIVE: Our objective was to identify genetic factors underlying the variability in weight loss outcomes after RYGB surgery. DESIGN: We conducted a genome-wide association study using a 2-stage phenotypic extreme study design. SETTING: Patients were recruited from a comprehensive weight loss program at an integrated health system. PATIENTS: Eighty-six obese (body mass index >35 kg/m(2)) patients who had the least percent excess body weight loss (%EBWL) and 89 patients who had the most %EBWL at 2 years after surgery were genotyped using Affymetrix version 6.0 single-nucleotide polymorphism (SNP) arrays. A second group from the same cohort consisting of 164 patients in the lower quartile of %EBWL and 169 from the upper quartile were selected for evaluation of candidate regions using custom SNP arrays. INTERVENTION: We performed RYGB surgery. MAIN OUTCOME MEASURES: We assessed %EBWL at 2 years after RYGB and SNPs. RESULTS: We identified 111 SNPs in the first-stage analysis whose frequencies were significantly different between 2 phenotypic extremes of weight loss (allelic χ(2) test P < .0001). Linear regression of %EBWL at 2 years after surgery revealed 17 SNPs that approach P < .05 in the validation stage and cluster in or near several genes with potential biological relevance including PKHD1, HTR1A, NMBR, and IGF1R. CONCLUSIONS: This is the first genome-wide association study of weight loss response to RYGB. Variation in weight loss outcomes after RYGB may be influenced by several common genetic variants.
CONTEXT: Roux-en-Y gastric bypass (RYGB) is among the most effective treatments for extreme obesity and obesity-related complications. However, despite its potential efficacy, many patients do not achieve and/or maintain sufficient weight loss. OBJECTIVE: Our objective was to identify genetic factors underlying the variability in weight loss outcomes after RYGB surgery. DESIGN: We conducted a genome-wide association study using a 2-stage phenotypic extreme study design. SETTING:Patients were recruited from a comprehensive weight loss program at an integrated health system. PATIENTS: Eighty-six obese (body mass index >35 kg/m(2)) patients who had the least percent excess body weight loss (%EBWL) and 89 patients who had the most %EBWL at 2 years after surgery were genotyped using Affymetrix version 6.0 single-nucleotide polymorphism (SNP) arrays. A second group from the same cohort consisting of 164 patients in the lower quartile of %EBWL and 169 from the upper quartile were selected for evaluation of candidate regions using custom SNP arrays. INTERVENTION: We performed RYGB surgery. MAIN OUTCOME MEASURES: We assessed %EBWL at 2 years after RYGB and SNPs. RESULTS: We identified 111 SNPs in the first-stage analysis whose frequencies were significantly different between 2 phenotypic extremes of weight loss (allelic χ(2) test P < .0001). Linear regression of %EBWL at 2 years after surgery revealed 17 SNPs that approach P < .05 in the validation stage and cluster in or near several genes with potential biological relevance including PKHD1, HTR1A, NMBR, and IGF1R. CONCLUSIONS: This is the first genome-wide association study of weight loss response to RYGB. Variation in weight loss outcomes after RYGB may be influenced by several common genetic variants.
Authors: Ryan D Pooley; Katherine L Moynihan; Victor Soukoulis; Samyukta Reddy; Richard Francis; Cecilia Lo; Li-Jun Ma; David M Bader Journal: J Cell Sci Date: 2008-09-30 Impact factor: 5.285
Authors: Xin Chu; Robert Erdman; Meghan Susek; Heather Gerst; Kimberly Derr; Mouna Al-Agha; G Craig Wood; Christina Hartman; Stephanie Yeager; Mary Ann Blosky; Wanda Krum; Walter F Stewart; David Carey; Peter Benotti; Christopher D Still; Glenn S Gerhard Journal: Arch Surg Date: 2008-03
Authors: Alfredo M Carbonell; Luke G Wolfe; Jill G Meador; Harvey J Sugerman; John M Kellum; James W Maher Journal: Surg Obes Relat Dis Date: 2007-12-11 Impact factor: 4.734
Authors: Guilherme M Campos; Charlotte Rabl; Kathleen Mulligan; Andrew Posselt; Stanley J Rogers; Antonio C Westphalen; Feng Lin; Eric Vittinghoff Journal: Arch Surg Date: 2008-09
Authors: Dawn K Coletta; Bogdan Balas; Alberto O Chavez; Muhammad Baig; Muhammad Abdul-Ghani; Sangeeta R Kashyap; Franco Folli; Devjit Tripathy; Lawrence J Mandarino; John E Cornell; Ralph A Defronzo; Christopher P Jenkinson Journal: Am J Physiol Endocrinol Metab Date: 2008-03-11 Impact factor: 4.310
Authors: Vijay K Yadav; Franck Oury; Nina Suda; Zhong-Wu Liu; Xiao-Bing Gao; Cyrille Confavreux; Kristen C Klemenhagen; Kenji F Tanaka; Jay A Gingrich; X Edward Guo; Laurence H Tecott; J John Mann; Rene Hen; Tamas L Horvath; Gerard Karsenty Journal: Cell Date: 2009-09-04 Impact factor: 41.582
Authors: Elena G Bochukova; Ni Huang; Julia Keogh; Elana Henning; Carolin Purmann; Kasia Blaszczyk; Sadia Saeed; Julian Hamilton-Shield; Jill Clayton-Smith; Stephen O'Rahilly; Matthew E Hurles; I Sadaf Farooqi Journal: Nature Date: 2009-12-06 Impact factor: 49.962
Authors: Laura J Rasmussen-Torvik; Abigail S Baldridge; Jennifer A Pacheco; Sharon A Aufox; Kwang-Youn A Kim; Jonathan C Silverstein; Erwin W Denham; Eric Hungness; Maureen E Smith; Philip Greenland Journal: Obes Surg Date: 2015-11 Impact factor: 4.129
Authors: Sean Manning; Andrea Pucci; Nicholas C Carter; Mohamed Elkalaawy; Giorgia Querci; Silvia Magno; Anna Tamberi; Nicholas Finer; Alberic G Fiennes; Majid Hashemi; Andrew D Jenkinson; Marco Anselmino; Ferruccio Santini; Marco Adamo; Rachel L Batterham Journal: Surg Endosc Date: 2014-09-20 Impact factor: 4.584
Authors: Ankita Parihar; G Craig Wood; Xin Chu; Qunjan Jin; George Argyropoulos; Christopher D Still; Alan R Shuldiner; Braxton D Mitchell; Glenn S Gerhard Journal: Front Genet Date: 2014-08-05 Impact factor: 4.599